J. Watkins

发表

Low‐dose weekly platinum‐based chemoradiation for advanced head and neck cancer

M. B. Gillespie, T. Day, J. Watkins, 2010, The Laryngoscope.

High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas

E. Garrett-Mayer, J. Watkins, P. Giglio, 2009, Journal of Neuro-Oncology.

Toxicity, response rates and survival outcomes of induction cisplatin and irinotecan followed by concurrent cisplatin, irinotecan and radiotherapy for locally advanced esophageal cancer.

C. Reed, J. Watkins, A. J. Zauls, 2011, Japanese journal of clinical oncology.

Cisplatin/Irinotecan Versus Carboplatin/Paclitaxel as Definitive Chemoradiotherapy for Locoregionally Advanced Esophageal Cancer

C. Reed, J. Watkins, K. Shirai, 2010, American journal of clinical oncology.

Mastectomy Scar Boost Results in Low Risk of Locoregional Recurrence in the Setting of Close or Involved Surgical Margins

J. Watkins, Natalie Lichter, L. Johnson, 2014 .

Synchronous presentation of advanced rectal and intermediate-risk prostate cancers: a multidisciplinary approach

J. Watkins, N. Koleilat, T. Dufan, 2012 .

High‐dose fractionated radiotherapy to 80 Gy for stage I–II medically inoperable non‐small‐cell lung cancer

G. Silvestri, J. Watkins, A. J. Zauls, 2010, Journal of medical imaging and radiation oncology.

Requirement of percutaneous endoscopic gastrostomy tube placement in head-and-neck cancer treated with definitive concurrent chemoradiation therapy: An analysis of clinical and anatomic factors.

J. Lucas, J. Watkins, A. J. Zauls, 2013, Practical radiation oncology.

Salvage Resection for Isolated Local and/or Regional Failure of Head/Neck Cancer Following Definitive Concurrent Chemoradiotherapy Case Series and Review of the Literature.

M. B. Gillespie, J. Watkins, K. Shirai, 2011, McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students.

Involved‐field radiotherapy with concurrent chemotherapy for limited‐stage small‐cell lung cancer: Disease control, patterns of failure and survival

G. Silvestri, J. Watkins, A. J. Zauls, 2010, Journal of medical imaging and radiation oncology.

Impact of Treatment Time on Outcome for Resected Head and Neck Squamous Cell Carcinoma by HPV Status

Nitin A. Pagedar, J. Buatti, J. Watkins, 2020 .

Incidental prostate cancer diagnosed at radical cystoprostatectomy for bladder cancer: disease-specific outcomes and survival

J. Buatti, Mark C. Smith, M. O'Donnell, 2016, Prostate international.

An exploratory study of the relation of population density and agricultural activity to hematologic malignancies in North Dakota.

J. Watkins, Patricia L. Watkins, 2013, WMJ : official publication of the State Medical Society of Wisconsin.

Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy.

J. Watkins, A. J. Zauls, E. Garrett-Mayer, 2010, American journal of surgery.

Pancreaticoduodenectomy: A 20-year experience in 516 patients

A. J. Donovan, K. Lillemoe, O. Cummings, 2004 .

Imaging applications in multicatheter brachytherapy for soft tissue sarcomas

J. Watkins, J. Harper, Jun Li, 2010, Cancer imaging : the official publication of the International Cancer Imaging Society.

Helical tomotherapy for total lymphoid irradiation

J. Watkins, J. Jenrette, M. Ashenafi, 2008, Radiation Medicine.

Irradiation of Donor Mononuclear Cells for Treatment of Chemorefractory Metastatic Solid Cancers: A Community-Based Immune Transplant Pilot Study

J. T. Reynolds, J. Watkins, S. Kubsad, 2012, Cancer research and treatment : official journal of Korean Cancer Association.

Ultrasound‐guided tandem placement for low‐dose‐rate brachytherapy in advanced cervical cancer minimizes risk of intraoperative uterine perforation

M. Kohler, J. Watkins, S. Ackerman, 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Effect of Body Mass Index on Chemoradiation Outcomes in Head and Neck Cancer

Theodore R. McRackan, M. B. Gillespie, T. Day, 2008, The Laryngoscope.

Radiation therapy for palliation of Eisenmenger’s syndrome-associated painful splenomegaly

C. Strange, J. Watkins, J. Jenrette, 2008, Radiation Medicine.

Toxicity and survival outcomes of hyperfractionated split‐course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers

M. B. Gillespie, T. Day, J. Watkins, 2009, Head & neck.

A Case of Orbital Rosai-Dorfman Disease Responding to Radiotherapy

M. Caplan, J. Watkins, J. Jenrette, 2008, Journal of pediatric hematology/oncology.

Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer.

J. Watkins, K. Shirai, E. Garrett-Mayer, 2009, International journal of radiation oncology, biology, physics.

Radioiodine Ablation following Thyroidectomy for Differentiated Thyroid Cancer: Literature Review of Utility, Dose, and Toxicity 

Nitin A. Pagedar, J. Buatti, J. Watkins, 2017, European Thyroid Journal.

Individualization of Adjuvant Therapy After Radical Prostatectomy for Clinically Localized Prostate Cancer: Current Status and Future Directions.

Chad R. Tracy, J. Buatti, J. Watkins, 2016, Clinical genitourinary cancer.

A Recursive Partitioning Analysis Demonstrating Risk Subsets for 8-Year Biochemical Relapse After Margin-Positive Radical Prostatectomy Without Adjuvant Hormone or Radiation Therapy

Chad R. Tracy, J. Buatti, J. Watkins, 2021, Advances in radiation oncology.

Total Lymphoid Irradiation For The Treatment Of Refractory Bronchiolitis Obliterans Following Allogeneic Hematopoietic Stem Cell Transplantation

J. Lewis, J. Watkins, J. Kraveka, 2010 .

Comparing high‐dose cisplatin with cisplatin‐based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)

G. Clamon, J. Watkins, C. Anderson, 2019, Cancer medicine.

Long-term outcome comparison for standard fractionation (>59 Gy) versus hyperfractionated (>45 Gy) radiotherapy plus concurrent chemotherapy for limited-stage small-cell lung cancer.

J. Buatti, J. Watkins, Anand K. Sharma, 2020, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

The Impact of Weight Change During and After Post-Operative Chemotherapy on Breast Cancer Control in Node-Positive Patients Treated With Trimodality Therapy

Joshua R. Johnson, J. Watkins, Patricia L. Watkins, 2014 .

Margin involvement at prostatectomy for clinically localized prostate cancer: does a low-risk group exist?

J. Watkins, Patricia L. Watkins, T. Dufan, 2015, Practical radiation oncology.

Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung Cancer.

J. Buatti, D. Spitz, Tangel Chang, 2016, Journal of oncology translational research.

Once-daily radiotherapy to ≥59.4 Gy versus twice-daily radiotherapy to ≥45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomes

A. Turrisi, J. Watkins, K. Shirai, 2010, Japanese Journal of Radiology.

Gleason Score ≤ 6 Prostate Cancer at Radical Prostatectomy: Does a High‐Risk Setting Truly Exist? A Recursive Partitioning Analysis

Chad R. Tracy, J. Buatti, J. Watkins, 2017, Clinical genitourinary cancer.

Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups.

J. Watkins, A. J. Zauls, E. Garrett-Mayer, 2012, International journal of radiation oncology, biology, physics.

Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy.

D. Sinha, J. Watkins, D. Cole, 2008, Brachytherapy.

Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy Alone

Chad R. Tracy, J. Buatti, J. Watkins, 2017, Pathology & Oncology Research.

What is the optimal management of Gleason score 7 prostate cancer at biopsy? A comparison of disease control for prostatectomy versus radiotherapy.

J. Watkins, N. Koleilat, Patricia L. Watkins, 2015, Clinical genitourinary cancer.

Margin details matter: The prognostic significance of pseudocapsule invasion at the site of involved margin in prostatectomy specimens.

J. Watkins, N. Koleilat, J. K. Russo, 2015, Urologic oncology.

High-grade prostate adenocarcinoma (Gleason Score ≥8): survival and disease control following radical prostatectomy versus radiotherapy plus long-course hormone therapy

J. Watkins, N. Koleilat, Patricia L. Watkins, 2015, Journal of Radiation Oncology.

Definitive radiotherapy for medically inoperable early-stage serous and clear cell uterine carcinoma

J. Watkins, J. Jenrette, Emma C. Batchelor, 2007, Radiation Medicine.

High-grade prostate adenocarcinoma: survival and disease control after radical prostatectomy

J. Watkins, N. Koleilat, Patricia L. Watkins, 2013 .

The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma.

D. Sinha, M. Kohler, J. Watkins, 2008, European journal of obstetrics, gynecology, and reproductive biology.

What is the optimal management of Gleason score 7 prostate cancer at biopsy? A comparison of disease control for prostatectomy versus radiotherapy.

J. Watkins, N. Koleilat, Patricia L. Watkins, 2015, Clinical genitourinary cancer.